Pincus Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02M Sell
2,521
-10
-0.4% -$10.2K 1.8% 11
2026
Q1
$2.33M Sell
2,531
-24
-0.9% -$24.3K 1.62% 13
2025
Q4
$2.75M Buy
+2,555
New +$2.44M 1.83% 13

Other funds holding LLY

Pincus Capital Management's LLY Position: Q2 2026 in Review

Pincus Capital Management reduced its Eli Lilly (LLY) stake by 0.4% in Q2 2026, selling an estimated $10.2K and leaving 2,521 shares worth $3.02M. The position accounts for 1.8% of the portfolio, ranked #11.

Pincus Capital Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Pincus Capital Management held 2,521 shares of Eli Lilly worth $3.02M as of Q2 2026.
  • Pincus Capital Management sold 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
  • Eli Lilly made up 1.8% of Pincus Capital Management's portfolio in Q2 2026, its #11 holding.
  • Pincus Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pincus Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.